Stock FLERIE FLERIE INVEST AB
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Flerie Invest AB

Equities

FLERIE

SE0008966295

Market Closed - Nasdaq Stockholm
Other stock markets
 12:00:00 2024-07-03 pm EDT 		5-day change 1st Jan Change
0.464 SEK -2.11% Intraday chart for Flerie Invest AB -3.33% +85.16%
Jun. 28 Flerie AB(OM:FLERIE) added to OMX Nordic All-Share Index CI
Jun. 14 Alligator Bioscience Names New CFO MT

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
InDex Pharmaceuticals completes reverse merger with Flerie
AQ
Bulletin from the Extraordinary General Meetings in InDex Pharmaceuticals Holding AB (publ) on June 10, 2024
AQ
InDex Pharmaceuticals has received a conditional approval for continued listing on Nasdaq First North Growth Market after the reverse merger of Flerie
AQ
InDex Pharmaceuticals publishes NAV for Flerie as of May 31, 2024
AQ
InDex Pharmaceuticals publishes company description in connection with the reverse merger of Flerie
AQ
Flerie makes its way to the stock market via InDex
AQ
InDex Pharmaceuticals has entered into a conditional agreement regarding a reverse merger with Flerie
AQ
Bulletin from the Annual General Meeting in InDex Pharmaceuticals Holding AB (publ)
AQ
Notice of extraordinary general meeting in InDex Pharmaceuticals Holding AB (publ)
AQ
InDex Pharmaceuticals provides a status update and informs about Extraordinary General Meeting on June 10, 2024
AQ
InDex Pharmaceuticals Holding AB (publ) interim report January - March 2024
AQ
InDex Pharmaceuticals brings forward the publication of the interim report for Q1 2024
AQ
InDex Pharmaceuticals provides a company update
AQ
InDex Pharmaceuticals Holding AB (publ) publishes Annual Report for 2023
AQ
Notice of Annual General Meeting in InDex Pharmaceuticals Holding AB (publ)
AQ
CEO and CFO both to leave InDex Pharmaceuticals
AQ
InDex Pharmaceuticals provides an update on company's future
AQ
InDex Pharmaceuticals discontinues the development of cobitolimod
AQ
InDex Pharmaceuticals Holding AB (publ) year-end report 2023
AQ
InDex Pharmaceuticals announces expected cash balance per March 31, 2024
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. FLERIE Stock
  4. News Flerie Invest AB
  5. Press Releases